comparemela.com

Latest Breaking News On - ம் தொழில்நுட்பம் - Page 1 : comparemela.com

Corigine Delivers a Next-Generation Prototyping System for ASIC and Pre-Silicon Software Development

Corigine Delivers a Next-Generation Prototyping System for ASIC and Pre-Silicon Software Development
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

ATLANT 3D Secures NASA as Customer

ATLANT 3D Secures NASA as Customer
azonano.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from azonano.com Daily Mail and Mail on Sunday newspapers.

VISEN s TransCon Human Growth Hormone Phase-III Clinical Trial in China Completes Target Patient Recruitment Number as Scheduled

VISEN s TransCon Human Growth Hormone Phase-III Clinical Trial in China Completes Target Patient Recruitment Number as Scheduled
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

DGAP-News: Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis

DGAP-News: Imcys . DGAP-News: Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis vom 03.02.2021, 14:00 Uhr Bild: pixabay.com DGAP-News: Imcyse SA / Key word(s): Agreement Imcyse Enters into Research Collaboration and License Agreement for its ImotopeTM Technology with Pfizer in Rheumatoid Arthritis 03.02.2021 / 14:00 Imcyse Enters into Research Collaboration and License Agreement for its Imotope TM Technology with Pfizer in Rheumatoid Arthritis Imcyse and Pfizer to collaborate to develop Imotope TM candidates to potentially treat Rheumatoid Arthritis Pfizer to lead clinical development and commercialization activities Imcyse to receive upfront payment in cash and through the purchase of equity in addition to milestone up to $180 million and tiered royalty payments

Panasonic Air Conditioners with nanoe™ X confirmed to inhibit the novel coronavirus

January 25, 2021 | 3:20 pm Font Size AAA Global contract research organization certifies the inhibitory effect of Panasonic Air Conditioners with nanoe™ X Technology on the Novel Coronavirus: 91.4% in 8 hours in a 6.7m 3 space Panasonic Manufacturing Philippines Corporation (PMPC) announced today a new breakthrough confirming that the inhibitory effect on the novel coronavirus (SARS-CoV-2) by the Panasonic Air Conditioner with nanoe™ X Technology was certified by Texcell 1, a global contract research organization.   3 in 8 hours. In September 2020, Panasonic has verified, in collaboration with Texcell, the inhibitory effect of the nanoe™ X Technology with the benefits of hydroxyl radicals on the novel coronavirus in a small test space of 45L using the nanoe™ X generator.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.